Huitianfu Fund announced that after agreement with the fund's custodian, it was decided to value the suspended stock “Qiming Medical-B (stock code: 2500.HK)” held by some of its funds at HK$4.215 per share starting March 18, 2024. The company will pay close attention to the company's subsequent operations and other important matters and make reasonable assessments. After the stock resumes trading and shows the characteristics of active market trading, it will revert to using the closing price of the day for valuation, and there will be no separate announcement at that time.
汇添富基金：对停牌股票“启明医疗-B”按照4.215港元/股估值
Huitianfu Fund: The suspended stock “Qiming Medical-B” is valued at HK$4.215 per share
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.